OVERVIEW

ONSITE Program Books / Handouts

Preventing Harassment & Violence in Healthcare

Date: October 2019 to October 2020

This activity is provided by SynAptiv and Dist-Learn, LLC d/b/a National Healthcare ED.

Goal/Purpose of Activity
The goal of this activity is to reduce sexual harassment, bullying, and violence in the healthcare workplace. Doing this is aimed at improving the working environment for clinicians and patient care.

Educational Objectives:
After completing this activity, the participant should be better able to:
• Identify, prevent, and react to sexual harassment in the medical workplace.
• Discuss of the types of workplace bullying, the negative effects on care, and actions that can be taken against such behavior.
• Describe the physical and psychological factors surrounding a violent environment in healthcare, prevalent types of workplace violence, and relevant organizations with resources and authority in the area.
• Explain where to run, who to fight, and how to hide to save lives in the case of potentially lethal physical violence.

Faculty / Content Developers - List faculty with complete titles and affiliations.
• Robert W. Casazza. President, Metropolitan Healthcare Security Directors Association (MHSDA).
• Joseph Sweeney. Vice President, MHSDA.
• Dr. Tom Royer, MD. CEO Emeritus of CHRISTUS Healthcare. CEO and Partner, Royer-Maddox-Herron Advisors.
• Gary D Slack, PE. President, Healthcare Engineering Consultants.
• H. Jack Rutledge. President, National Healthcare ED.

Physician Accreditation Statement

synaptiv

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the providership of SynAptiv. SynAptiv is accredited by the ACCME to provide continuing medical education for physicians.

SynAptiv designates this enduring material activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

SynAptiv ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, SynAptiv identifies conflicts of interest with its instructors, planners, content managers, and other individuals who are in a position to control the content of an activity.

The following faculty, planner and/or content manager reported the following financial relationship with commercial interests whose products or services may be mentioned in this CE activity:

Name of Individual

Reported Financial Relationship

Thomas C. Royer CEO/Partner for Royer-Maddow-Heron Advisors

All other faculty, planner and/or content managers have nothing to disclose nor do they have any vested interests or affiliations. All conflicts of interest have been resolved.

Disclaimer Statement –

The content, views and opinions presented in this educational activity are those of the faculty/authors and do not necessarily reflect those of SynAptiv. The faculty/authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.